186 related articles for article (PubMed ID: 18202808)
1. Corn-derived carbohydrate inositol hexaphosphate inhibits Barrett's adenocarcinoma growth by pro-apoptotic mechanisms.
McFadden DW; Riggs DR; Jackson BJ; Cunningham C
Oncol Rep; 2008 Feb; 19(2):563-6. PubMed ID: 18202808
[TBL] [Abstract][Full Text] [Related]
2. Inositol hexaphosphate (IP6): a novel treatment for pancreatic cancer.
Somasundar P; Riggs DR; Jackson BJ; Cunningham C; Vona-Davis L; McFadden DW
J Surg Res; 2005 Jun; 126(2):199-203. PubMed ID: 15919420
[TBL] [Abstract][Full Text] [Related]
3. Inositol hexaphosphate (IP6) inhibits cellular proliferation in melanoma.
Rizvi I; Riggs DR; Jackson BJ; Ng A; Cunningham C; McFadden DW
J Surg Res; 2006 Jun; 133(1):3-6. PubMed ID: 16563438
[TBL] [Abstract][Full Text] [Related]
4. Peptide YY inhibits the growth of Barrett's esophageal adenocarcinoma in vitro.
McFadden DW; Riggs DR; Jackson BJ; Vona-Davis L
Am J Surg; 2004 Nov; 188(5):516-9. PubMed ID: 15546561
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
Vona-Davis L; Riggs DR; Jackson BJ; McFadden DW
J Surg Res; 2004 Jun; 119(2):143-8. PubMed ID: 15145696
[TBL] [Abstract][Full Text] [Related]
6. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
[TBL] [Abstract][Full Text] [Related]
7. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
Konturek PC; Kania J; Burnat G; Hahn EG
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
[TBL] [Abstract][Full Text] [Related]
8. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line.
Jaiswal K; Lopez-Guzman C; Souza RF; Spechler SJ; Sarosi GA
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G335-42. PubMed ID: 16239404
[TBL] [Abstract][Full Text] [Related]
9. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
[TBL] [Abstract][Full Text] [Related]
10. Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
Janus SC; Weurtz B; Ondrey FG
Laryngoscope; 2007 Aug; 117(8):1381-8. PubMed ID: 17607147
[TBL] [Abstract][Full Text] [Related]
11. Effect of phytic acid and inositol on the proliferation and apoptosis of cells derived from colorectal carcinoma.
Schröterová L; Hasková P; Rudolf E; Cervinka M
Oncol Rep; 2010 Mar; 23(3):787-93. PubMed ID: 20127021
[TBL] [Abstract][Full Text] [Related]
12. MAPK and PI3K inhibition reduces proliferation of Barrett's adenocarcinoma in vitro.
Vona-Davis L; Frankenberry K; Cunningham C; Riggs DR; Jackson BJ; Szwerc MF; McFadden DW
J Surg Res; 2005 Jul; 127(1):53-8. PubMed ID: 15964304
[TBL] [Abstract][Full Text] [Related]
13. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo.
Vucenik I; Kalebic T; Tantivejkul K; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1377-84. PubMed ID: 9673344
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms for the antitumor activity of inositol hexakisphosphate (IP6).
Bozsik A; Kökény S; Olah E
Cancer Genomics Proteomics; 2007; 4(1):43-51. PubMed ID: 17726240
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A
Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323
[TBL] [Abstract][Full Text] [Related]
16. Dietary influence on pancreatic cancer growth by catechin and inositol hexaphosphate.
McMillan B; Riggs DR; Jackson BJ; Cunningham C; McFadden DW
J Surg Res; 2007 Jul; 141(1):115-9. PubMed ID: 17574044
[TBL] [Abstract][Full Text] [Related]
17. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
Ogunwobi OO; Beales IL
Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
[TBL] [Abstract][Full Text] [Related]
18. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
[TBL] [Abstract][Full Text] [Related]
19. Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation.
Beales IL; Ogunwobi OO
J Mol Endocrinol; 2009 Apr; 42(4):305-18. PubMed ID: 19153190
[TBL] [Abstract][Full Text] [Related]
20. Statins in esophageal cancer cell lines: promising lead?
Hawk ET; Viner JL
Am J Gastroenterol; 2008 Apr; 103(4):838-41. PubMed ID: 18371147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
